Cancer clinical trials in the region Corse

17 currently recruiting clinical trials
Region Corse

Early Access Lymphoma
B cell lymphoma Large B cell lymphoma 1
Systemic Treatment-Naive
Hoffmann-La Roche
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR 1 Targeted therapy
Systemic Treatment-Naive
Janssen
Early Access Bladder / Urinary Tract / Urethral cancer
Invasive bladder cancer Urothelial carcinoma Locally Advanced Metastatic None Systemic Treatment-Naive
Merck Sharp & Dohme LLC
Early Access Stomach and esophageal cancer
Stomach Oesogastric junction Adenocarcinoma Locally Advanced Metastatic HER2 PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) PDL1 Positive (>= 50%) None Systemic Treatment-Naive
Merck Sharp & Dohme LLC
Early Access Bladder / Urinary Tract / Urethral cancer
Invasive bladder cancer Urothelial carcinoma Locally Advanced Metastatic None Systemic Treatment-Naive
Astellas Pharma Développement mondial, Inc.
Early Access Kidney cancer Pancreas cancer
Clear cell carcinoma Neuroendocrine tumor Localized Von Hippel-Lindau syndrome (VHL)
Merck Sharp & Dohme LLC
Early Access Endometrial cancer
Stage III Stage IV Locally Advanced Metastatic MSI/dMMR None 1
GlaxoSmithKline
Early Access Endometrial cancer
Stage III Stage IV Locally Advanced Metastatic MSS None 1
MSI/dMMR
GlaxoSmithKline
Early Access Stomach and esophageal cancer
Stomach Oesogastric junction Adenocarcinoma Locally Advanced Metastatic Claudin 18.2 PDL1 Negative (< 1%) None Systemic Treatment-Naive
HER2
Astellas Pharma Développement mondial, Inc.
Early Access Liver and bile duct cancer
Intrahepatic cholangiocarcinoma Extrahepatic cholangiocarcinoma Locally Advanced Metastatic HER2 1 2 3 or more Chemotherapy
Systemic Treatment-Naive
Jazz Pharmaceuticals